Dataset Information


Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases.

ABSTRACT: BACKGROUND: The abnormality of interleukin-21 (IL-21)-IL-21-receptor (IL-21R) system has been found in many autoimmune diseases including autoimmune thyroid diseases (AITDs). In this study, we investigated whether polymorphisms of the IL-21 and IL-21R are associated with Graves' disease (GD) and Hashimoto's thyroiditis (HT), two major forms of AITDs, among a Chinese population. METHODS: Rs907715, rs4833837, rs2221903 and rs2055979 of the IL-21 gene and rs3093301 and rs2285452 of the IL-21R gene were explored in a case-control study including 405 GD, 228 HT patients and 242 controls. These genes were genotyped by the PCR and restriction fragment length polymorphism (RFLP) analysis and the MASS spectrometry method. RESULTS: For IL-21 gene, we identified and confirmed a higher prevalence of A alleles of rs2221903 (P?=?0.018, OR?=?1.50 95% CI?=?1.07-2.09) in GD patients. We also found a significant association between rs2221903 and HT (allele: P?=?0.009, OR?=?1.69 95% CI?=?1.13-2.51; genotype: recessive P?=?0.021, OR?=?11.72 95% CI?=?1.46-94.13). For the IL-21R gene, compared with controls, the genotype frequencies of rs3093301 and rs2285452 were significantly different in HT patients using dominant genetic model (P?=?0.023, OR?=?1.61 95% CI?=?1.07-2.42; P?=?0.031, OR?=?1.71 95% CI?=?1.05-2.80, respectively). Furthermore, the haplotype AA containing the major alleles of rs4833837 and rs2221903 was associated with increased susceptibility to GD with an OR of 1.50(95% CI =1.08-2.09, P?=?0.016), and to HT with an OR of 1.69(95% CI =1.14-2.52, P?=?0.009). CONCLUSION: Our results indicated that the SNPs of the IL-21 gene is associated with the development of GD. In addition, we found that individuals with the SNPs of the common IL-21 and IL-21R may have higher risk of HT.


PROVIDER: S-EPMC3766107 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5575225 | BioStudies
2018-01-01 | S-EPMC5999507 | BioStudies
2019-01-01 | S-EPMC6595330 | BioStudies
2019-01-01 | S-EPMC7167994 | BioStudies
2015-01-01 | S-EPMC4422281 | BioStudies
2015-01-01 | S-EPMC4387902 | BioStudies
2020-01-01 | S-EPMC7081108 | BioStudies
2020-01-01 | S-EPMC7160246 | BioStudies
2015-01-01 | S-EPMC4694492 | BioStudies
2014-01-01 | S-EPMC4065265 | BioStudies